托维妥单抗
Tovetumab (Anti-PDGFRA / CD140a)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
1 mg 5 mg 10 mg 50 mg 100 mg
Product Availability
3-5days
Price
$800.00
Member price
Product Availability
3-5days
Price
$2300.00
Member price
Product Availability
3-5days
Price
$4200.00
Member price
Product Availability
3-5days
Price
$18500.00
Member price
Product Availability
3-5days
Price
$34000.00
Member price
Quantity
- +
Product Overview
Product Name Tovetumab (Anti-PDGFRA / CD140a)
CAS1243266-04-7
Storage condition Store at 2 to 8 °C for 1-2 weeks. Store at -20 °C for 12 months. Store at -80 °C for long term storage. Use a manual defrost freezer and avoid repeated freeze-thaw cycles, away from light.
Security information
Product details

Tovetumab (Anti-PDGFRA / CD140a) is a fully humanized IgG2κ monoclonal antibody directed against the platelet-derived growth factor receptor (PDGFR) alpha with potential antineoplastic activity. It has a potential to be used in research of glioblastoma and non-small cell lung cancer (NSCLC). MW :145 kD.

Related literature
Related
Sorry, no related items
History
Epothilone B (Synonyms: EPO 906; Patupilone)
Kainic Acid Monohydrate (Synonyms: Kainic acid hydrate)
Etaracizumab
Sibrotuzumab
Tovetumab (Anti-PDGFRA / CD140a)
Batoprotafib (Synonyms: TNO155); (3S,4S)-8-(6-Amino-5-((2-amino-3-chloropyridin-4-yl)thio)pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine
Sodium 4-pentynoate
Limaprost (Synonyms: 17α,20-dimethyl-δ2-PGE1; ONO1206; OP1206)
Suzetrigine (Synonyms: VX-548)
Dubermatinib (Synonyms: TP-0903)